US Codex
Bill
Notes

S. 2512 — what changed

Adding Zika Virus to the FDA Priority Review Voucher Program Act

From Reported in Senate to Engrossed in Senate. 1 section amended between Reported in Senate and Engrossed in Senate.

Sec. 2 Expanding tropical disease product priority review voucher program to encourage treatments for Zika Virus Disease

changed Section 524(a)(3) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360n) 360n(a)(3)) is amended—

(1)
changed by redesignating subparagraph (R) as subparagraph (S); and(S);
(2)
added in subparagraph (Q), by striking “Filoviruses” and inserting “Filovirus Diseases”; and
(3)
renumbered was (4) by inserting after subparagraph (Q) the following:

added “(R) Zika Virus Disease.”

removed “(R) Zika virus.”